Constipation • Intestinal transit • Anti-inflammatory • Reduction of gastro-intestinal discomfort • Inhibition of pathogenic E. coli • Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction […]
Bifidobacterium breve – BR03 (DSM 16604) Read More »
Inhibition of pathogens E. coli and Enterobacteriaceae
Bifidobacterium breve – B632 (DSM 24706) Read More »
Constipation • Intestinal transit • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Bifidobacterium longum – BL03 (DSM 16603) Read More »
Femme is a probiotic complex by SynBalance, specifically designed to support women’s intimate health.Femme has been clinically tested to confirm the effectiveness in humans. The first clinical trial has investigated the ability of probiotic strains to colonize and persist in the vagina through oral intake. In a RDBPC trial 40 healthy women were enrolled and
Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus acidophilus – LA02 (DSM 21717) Read More »
Gaseous colic • Inhibition of E. coli, including toxinogenic O157:H7 • Inhibition of Klebsiella pneumoniae and of different coliforms isolated from colicky infants • Inhibition of pathogens E. coli, Klebsiella and gas-producing coliforms
Lactobacillus delbrueckii subsp. delbrueckii – LDD01 (DSM 22106) Read More »
Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus paracasei – LPC09 (DSM 24243) Read More »
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus plantarum – LP01 (LMG P-21021) Read More »
Cystitis • Inhibition of E. coli
Lactobacillus plantarum – LP02 (LMG P-21020) Read More »
Production of reuterin and vitamin B12 • Anti-pathogen activity and immunostimulation (induction of IFN-gamma) • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus reuteri – LRE02 (DSM 23878) Read More »
Diarrhea • Inhibition of E. coli, including enterohemorrhagic O157:H7 • Cystitis • Inhibition of E. coli
Lactobacillus rhamnosus – LR04 (DSM 16605) Read More »
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus rhamnosus – LR06 (DSM 21981) Read More »
Inhibition of Enterococcus faecalis, Enterococcus faecium and Neisseria gonorrhoeae • Vaginal health • Prevention of urogenital infections • Inhibition of Candida
Lactobacillus salivarius – CRL1328 Read More »
Recurrent cystitis. Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 30020. Isolated from goat’s milk. The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003). Shelf life raw material: 12 months when stored below 8°C.
Lactobacillus paracasei P 30020 Read More »
Lactobacillus acidophilus PBS066 (DSM 24936), developed by SynBalance.Gastrointestinal Health • Urogenital health • Immune prevention • Cognitive function • Metabolic Health
Lactobacillus acidophilus PBS066 (DSM 24936) Read More »
Limosilactobacillus reuteri PBS072 (DSM 25175), developed by SynBalance.Gastrointestinal Health • Urogenital health • Cognitive function • Metabolic Health • Skin Health
Limosilactobacillus reuteri PBS072 (DSM 25175) Read More »
Lactiplantibacillus plantarum PBS067 (DSM 24937), developed by SynBalance.Gastrointestinal Health • Urogenital health • Metabolic Health • Skin Health • Immune prevention
Lactiplantibacillus plantarum PBS067 (DSM 24937) Read More »
Lactobacillus gasseri LG050 (LMG P-29638), developed by SynBalanceGastrointestinal Health • Urogenital health • Metabolic Health
Lactobacillus gasseri LG050 Read More »
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566), developed by SynBalance.Gastrointestinal Health • Urogenital health • Metabolic Health• Immune prevention
Bifidobacterium animalis subsp. lactis BL050 (DSM 25566) Read More »
MicrobiomeHUB is a space that brings together the companies of the microbiome industry
Brought to you by Clorofilla Scientific Publishing
This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
